Drug: ZOLEDRONIC ACID Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124195003 | ZOLEDRONIC ACID | Malignant neoplasm progression | JANSSEN | 67.00 YR | M | 0 | 20160701 | CZ |
125925441 | ZOLEDRONIC ACID | Malignant neoplasm progression | NOVARTIS | 45.00 YR | F | 0 | 20160726 | IN |
126001821 | ZOLEDRONIC ACID | Malignant neoplasm progression | NOVARTIS | 63.00 YR | F | 0 | 20160727 | US |
126164092 | ZOLEDRONIC ACID | Malignant neoplasm progression | NOVARTIS | 49.00 YR | M | 0 | 20160809 | DE |
128002371 | ZOLEDRONIC ACID | Malignant neoplasm progression | NOVARTIS | 0.00 | F | 0 | 20160930 | GR |
Total Records: 5 Number of Pages: 1